BeStock  
Stocks › Biotechnology › KRSA

Korsana Biosciences KRSA

US equityMarket cap rank #2789Biotechnology
$37.56 +$2.11 (+5.95%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $37.56 0.00%
Open$35.63
Prev close$35.45
Day range$34.08 – $39.41
Volume265.2K
Market cap$1.71B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-45.2x
CheapRich

Around its usual level · 51st percentile, 5-year average -44.5x

Price / book3.7x
CheapRich

Around its usual level · 49th percentile, 5-year average -4.6x

#4032 of 5330 stocks by PB (1 = cheapest)

P/E over five years

-58x-37x-16x4xSep '26Oct '26Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$37.20
Price vs. fair value+1.0%Close to the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 3.68 – -4.58 49% (cheaper than usual) #4032 of 5330 (1 = cheapest)
PE -45.21 -8.30 -44.49 51% (pricier than usual) –
PS – – 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on KRSA.

Sign in to join the discussion.

Scroll to Top